Hexosaminidase-A deficiency presenting as atypical juvenile-onset spinal muscular atrophy.

Three patients from two families had an unusual phenotypical variant of late-onset hexosaminidase-A deficiency. The clinical picture was dominated by spinal motor neuron involvement mimicking juvenile-onset spinal muscular atrophy. Atypical features included prominent muscle cramps, postural and action tremor, recurrent psychosis, incoordination, corticospinal and corticobulbar involvement, and dysarthria. The presence of these atypical features in patients whose lower motor neuron involvement would otherwise be consistent with juvenile-onset spinal muscular atrophy should raise the suspicion of the presence of hexosaminidase-A deficiency and GM2 gangliosidosis that can be proved by appropriate enzyme assays.

[1]  J. Bayleran,et al.  Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[2]  F. Andermann,et al.  Juvenile progressive dystonia: A new phenotype of GM2 Gangliosidosis , 1984, Annals of neurology.

[3]  S. Raghavan,et al.  GM2-gangliosidosis Hexosaminidase mutations not of the Tay-Sachs type procedure unusual clinical variants , 1983, Trends in Neurosciences.

[4]  R. Proia,et al.  Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Kin,et al.  Deficiency of the Hexosaminidase A Activator Protein in a Case of GM2 Gangliosidosis; Variant AB , 1982, Pediatric Research.

[6]  L. Rowland,et al.  Juvenile spinal muscular atrophy: A new hexosaminidase deficiency phenotype , 1981, Annals of neurology.

[7]  K. Jellinger,et al.  Adult GM2 gangliosidosis masquerading as slowly progressive muscular atrophy: motor neuron disease phenotype. , 1982, Clinical neuropathology.

[8]  R. Navon,et al.  Adult GM2 gangliosidosis in association with Tay‐Sachs disease , 1981, Neurology.

[9]  W. Johnson.  The clinical spectrum of hexosaminidase deficiency diseases , 1981, Neurology.

[10]  R. Desnick,et al.  Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia , 1981, Neurology.

[11]  O'Brien Js.  Suggestions for a nomenclature for the GM2 gangliosidoses making certain (possibly unwarrantable) assumptions. , 1978 .

[12]  M. Kaback,et al.  Tay-Sachs disease heterozygote detection: a quality control study. , 1977, Progress in clinical and biological research.

[13]  H. Galjaard,et al.  Characterization of β‐D‐N‐acetylhexosaminidases C and S in fibroplasts from control individuals and patients with tay‐sachs disease , 1976 .

[14]  I. Rapin,et al.  Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. , 1976, Archives of neurology.

[15]  E. Brett,et al.  Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients. , 1973, Archives of disease in childhood.

[16]  I. Rapin,et al.  Juvenile GM2‐gangliosidosis , 1970, Neurology.